Skip to main content
Regional health forum minutes

Regional health forum minutes - Dublin and North East 26 January

Minutes of the Regional health forum HSE Dublin and North East held on Monday 26 January 2026.

Meeting details

The minutes of the meeting held on Monday 24 November 2025 were adopted by the Forum on the proposal of Cllr. Michelle Hall and seconded by Cllr. John Paul Feeley.

Members Present

Cllr. Kieran Dennison, Cllr. John Paul Feeley, Cllr. Michelle Hall, Cllr. Mary McCamley, Cllr. Shane McGuinness, Cllr. Trevor Smith Cllr. Donna Cooney, Cllr. Deirdre Heney, Cllr. Alan Johnston, Cllr. Bronagh McAree, Cllr. Fiona Mhic Conchoille, Cllr. Edel Moran, Cllr. Cat O’Driscoll, Cllr. Tom O’Leary, Cllr. Conor Reddy, Cllr. Supriya Singh, Cllr. Áine Smith, Cllr. John Smyth, Cllr. Ellen Troy

Apologies

Cllr. Christy Burke, Cllr. Padraig Coffey, Cllr. Luke Corkery, Cllr. Nick Killian, Cllr. Caroline O’Reilly, Cllr. Paul O’Rourke

HSE Representatives Present

June Molloy, Communications Manager, Communications and Public Affairs, HSE Dublin and North East

Stephanie Dunne, Communications Manager, Communications and Public Affairs, HSE Dublin and North East

Karl Coleman, Senior Press Officer, Communications and Public Affairs, HSE Dublin and North East

Lorraine Timmons, Regional Health Office, HSE Dublin and North East

Dr. Cliona Murphy, National Clinical Director, Women’s and Infants Health Programme

Donal Cassidy, Head of Service Mental Health, IHA Dublin North County and Dublin North City & West

Caralyn Horne, Head of Service Primary Care, IHA Cavan Monaghan

Fiona Daly, Communications Officer, Public Health HSE Dublin and North East

Health Service Executive Updates

June Molloy, Communications Manager, Communications and Public Affairs, gave a report to the meeting which dealt with the following:

  • Soilse documentary shortlisted for an AONTAS STAR Award 2026
  • HSE marks Cervical Cancer Prevention Week 2026
  • HSE stop smoking advisors are your best help to QUIT for good in 2026
  • HSE reminds people of the dangers of sunbeds – Using sunbeds even once increases the risk of developing skin cancer

The following outlines comments and queries raised by members and responses from HSE representatives:

  • Uptake of cervical screening and participation rates

Details will be provided.

  • Vaccine uptake and whether boys are receiving it at same rate as girls

A response will be provided.

  • Evidence that negative experiences during screening discourage women from returning for future tests

A response will be provided.

  • Access to the HPV vaccine for people who missed it in school and up to what age can people receive the vaccine

If someone misses the vaccine at school, they can get it privately through GP services.

  • Clarification on the age / years when the HPV vaccine is offered, specifically for students who missed it in first year

The free HPV vaccine is offered to girls and boys in their first year of secondary school through the HSE National Immunisation Programme. From January 2026, the Laura Brennan HPV vaccine catch-up programme in secondary schools is giving students (aged between 16-19) in fifth and sixth year another chance to get the vaccine, if they didn’t get it in first year.

  • Suggestion that universities and colleges could offer vaccine on campus - proposal of a pilot programme at a few major universities

Suggestion noted.

  • Concerns in relation to sunbed use - misconceptions about sun exposure – suggestion that multilingual notices on cancer risk from sunbeds be displayed in salons

Comments and suggestion noted.

  • Current sunbed legislation

Sunbeds are currently still allowed, however, there are age restrictions (under 18s are banned).

  • Evidence that UV nail lamps could increase cancer risk in the fingertips

A response will be provided.

  • Praise for HSE Stop Smoking campaign - commend staff responsible for promoting the programme - great service for the local community

Comments will be passed to the Quit campaign.

  • HSE Quit Smoking campaign no longer feature real-life examples – suggestion of including diverse cohorts to reflect the variety of people who smoke

Comments noted.

The report was noted by the Forum.

Presentation on Endometriosis

Dr. Cliona Murphy, National Clinical Director, Women’s and Infants Health Programme, gave a presentation to members on Endometriosis.

The following outlines comments and queries raised by members and responses from HSE representatives.

  • Guidance and management of condition prior to 2020

Within Ireland and many other European countries, historically, endometriosis was managed in a fragmented way across clinics, with no specific plan or pathway. From approximately 2017, countries like France, the UK and Australia started developing policies or national strategies for Endometriosis.

  • Symptoms and comorbid conditions often not linked to Endometriosis and patients being misdiagnosed

Overlap of conditions can make diagnosis challenging, and GPs are cautious to avoid misdiagnosing serious conditions as Endometriosis. Some patients may have multiple coexisting conditions, and there is a genetic component to endometriosis, with family clusters sometimes seen. Early diagnosis is important as many women develop a tolerance to pain and may delay seeking help, normalising symptoms that are not typical.

  • Need for a multidisciplinary team for Endometriosis management, including neurology

Acknowledgement of importance of integrated care with clinicians across specialties, such as neurology and gynaecology, communicating to understand the full patient journey.

  • Clarification on surgeries for endometriosis, particularly advanced or end-stage cases

Surgery for endometriosis depends on the severity and type of disease. Superficial endometriosis: small visible lesions are often excised via laparoscopy. Most cases fall into this category. Complex disease: large nodules or organs stuck together may require longer, carefully planned surgeries, possibly using robotic-assisted minimal access surgery. Rare surgeries: very unusual cases may need to be done abroad because of low local case numbers and the need for specialised teams. Hysterectomy may be considered for women with adenomyosis who have completed their family, but for most endometriosis cases, it is not standard treatment.

  • Requirement for additional paid leave for women suffering with reproductive symptoms

Spain and Portugal have introduced period leave to acknowledge women’s reproductive health needs. Similar policies may spread across the EU. Women often face both biological challenges and caring responsibilities.

  • Clarification on whether the apparent rise in Endometriosis cases reflects an actual increase or just improved diagnosis

Endometriosis appears to be more prevalent now, partly due to modern lifestyle and biological factors including more menstrual cycles over a lifetime, genetic influences, environmental exposures and biological factors in cell development.

  • Management of cases through non-pharmacological interventions, including diet, supplements and sea dipping

Ancillary and non-invasive therapies are important for Endometriosis. Supplements, sea swimming and other wellbeing approaches should be explored by individuals as part of management.

  • Clarification on why Endometriosis is not considered a cancer

Endometriosis is not considered a cancer. Cancer involves rapid, uncontrolled cell growth and potential metastasis, whereas Endometriosis lesions grow slowly over time.

  • GP training and awareness of Endometriosis

The HSE works closely with the Irish College of General Practitioners (ICGP) to improve GP awareness of women’s health issues, including Endometriosis. Initiatives include weekly webinars on major topics and community gynaecology programmes, where GPs can upskill and earn diplomas in specific areas. Engagement varies among GPs, therefore, there may be differing levels of knowledge. Efforts are also being made to raise GP awareness through the Endometriosis Association, including posters and TV screens in surgeries.

  • Engagement with any patient advocacy groups

The HSE engages regularly with patient groups, such as Endometriosis Ireland, to gather feedback. Patients also reviewed the framework and provided input on language and perspectives. The presenter offered to engage with members who shared their personal journeys with Endometriosis at the meeting.

  • Request that presentation be circulated to include a glossary of acronyms

Noted.

  • Option on whether annual funding will be sufficient to achieve the aims and objectives of the framework

There are some concerns in relation to tracking funding and posts for Endometriosis services under the new regionalised system. Flexibility in funding means that earmarked posts might be repurposed where recruitment is difficult. However, this is acceptable if it continues to benefit services overall.

  • Sufficient staffing to implement the framework

The recruiting of some specialist staff can take time. However, encouraging clinicians to view Endometriosis care as a rewarding specialty has helped with recruitment. Specialist nurses are generally enthusiastic about new services, making recruitment easier. Roles like women’s health physiotherapists with an interest in Endometriosis are also attractive and easier to fill.

  • Education in schools in order that young girls understand normal menstrual pain versus potentially problematic

The Department of Education is rolling out a school programme on menstrual health aimed at teenagers. The focus is on understanding what is normal versus abnormal, providing a baseline for comparison. While the programme centres on periods, it is acknowledged that for many, the main issue is chronic pain and other symptoms not directly tied to menstruation.

  • Concerns that the contraceptive pill may mask symptoms

First-line medical treatment (like the pill) is generally preferred as early surgery can have disadvantages, such as adhesions and future complications. There is a need for more paediatric and adolescent gynaecologists, though some experts exist in the Rotunda, Coombe and Holles Street hospitals with international training experience.

  • Diagnostic methods for Endometriosis – option of hormonal blood tests

Currently, no blood test exists for diagnosing Endometriosis. A saliva test is under evaluation and undergoing trials in France. Which patient cohort it would benefit most is still being determined. If validated, it could become a useful diagnostic tool and potentially reduce the need for invasive laparoscopy.

  • Co-ordination between IVF clinics and the HSE

Suspected Endometriosis cases are now fast-tracked, with fertility hubs and Endometriosis hubs often co-located. Teams collaborate to determine whether surgery or IVF is best for each patient. Many fertility specialists have training in Endometriosis, ensuring they consider impacts on fertility, such as preserving ovarian reserve during surgery.

  • Endometriosis not just a menstrual issue, but a chronic women’s disease

Endometriosis is not merely a woman’s or menstrual issue, but a chronic disease. Its severity can be comparable to conditions like Crohn’s disease or rheumatoid arthritis. It significantly impacts daily life, planning, travel and overall wellbeing. There is a need for greater awareness and understanding among the whole population.

  • Challenges, including public waiting lists and travelling abroad

Challenges remain, including waiting lists and limited access to non-cancer gynaecology surgeries. Difficulties in recruiting specialists is linked to limited surgical opportunities outside major centres. Patients may travel abroad for treatment due to local delays; however, it is recommended they attend reputable centres providing continuity of care. Efforts are being made to improve surgical pathways, though inequalities between regions still exist.

  • Ryeqo medication for Endometriosis

Currently, only Endometriosis specialists can prescribe a hormonal treatment (combination of oestrogen and progesterone) as an alternative to injections for severe Endometriosis. It is mostly available to private patients. It is currently being evaluated by the Medicines Management Programme with early evidence suggesting it works well for some patients, though not all. Wider availability is expected within 6–12 months, potentially reducing the need for surgery and providing a less harsh alternative to injections.

  • Requests to invite someone to address the Forum to share their daily lived experience of Endometriosis and give members a better understanding on the impact of this chronic condition.

Members who shared their experiences will be contacted.

Motions

With regards to the answers to my previous questions, Mr. Clerkin states that there has been a sustained growth in demand for histopathology in the lab. They have therefore withdrawn a service from patients who do not hold a medical card. This is not the answer, as the demand is still there and these patients then need referral to the same hospital for outpatient services, plus day surgery, incorporating lab service, but later, and when the tumour is possibly more advanced and then, at greater cost to the HSE.

Important points

Solution

These cases, which will otherwise need referral to hospital, can be managed by some GPs trained and skilled to do so with the histopathology lab facility, as they have been doing many years in the area.

Solution

These cases can be outsourced through the hospital to the external labs if hospital histopathology cannot absorb.

I am calling for the retraction of this new system and back to what it has been prior to 2 February 2025.

Cllr. Shane McGuinness

Cllr. Shane McGuinness outlined concerns in relation to histopathology services at Our Lady of Lourdes Hospital, Drogheda, and the previous response which stated that there has been sustained growth and demand for the lab. He stated that it was important to note that the number of cases are still relatively low in the overall context of lab work. Cllr. McGuinness stated that Histopathology services are no different from routine blood or urine tests, and patients without medical cards should have equal access. He gave details of other hospitals where the service is provided locally for GPs.

Cllr. McGuinness proposed solutions such as outsourcing certain cases to external labs through the hospital, handled by trained GPs. He expressed disappointment that the situation still requires review.

June Molloy, Communications Manager, updated the meeting on the current status of the review stating that it was currently with the new CEO of Louth Hospitals and it is expected to be completed in the near future.

Cllr. McGuinness emphasised that working people without medical cards should not be treated differently from those with medical cards and that GPs in Dundalk and Drogheda do not differentiate between patients based on medical card status.

Cllr. Michelle Hall supported the Motion and criticised the perception of introducing a new clinic when the service had already existed, calling it deceptive and non-transparent. She raised concern about a two-tier system, where medical card holders can access services, but tax-paying patients cannot, effectively pushing people into private care.

Questions

The responses to the Questions were noted.

Chairperson’s Correspondence

Resignation and Appointment

The Chairperson, Cllr. Kieran Dennison, informed the meeting that Cllr. Eimear Carbone-Mangan has resigned from the Forum and Fingal County Council have nominated Cllr. Luke Corkery to replace Cllr. Carbone-Mangan.

Vote of Sympathy

The Chairperson extended condolences to Katherine Kellett, Regional Health Office on the passing of her Father Tommy.

Date and time of next meeting

The next meeting of the Regional Health Forum - Dublin and North East will take place on Monday 23 March 2026.


This is a beta version - your feedback will help us to improve it

Regional Health Dublin and North East meeting minutes 26 January 2026